Hattie Hayes is a journalist specializing in ophthalmology and eye health. She writes for Ophthalmology Times, covering topics such as new technologies in the field, drug approvals, surgical techniques, and industry news. With a focus on providing informative and up-to-date information, Hattie aims to keep readers informed about the latest advancements and trends in ophthalmology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Hattie Hayes' coverage primarily focuses on the healthcare and pharmaceutical industry, specifically in ophthalmology. She frequently features announcements, press releases, and industry-specific content related to medicines, pharmaceuticals, and scientific developments.
Given her extensive coverage of the European Medicines Agency (EMA) recommendations and safety recalls for medical treatments, Hattie would likely be interested in experts who can provide insights into regulatory changes impacting this sector or those with a deep understanding of specific medications or treatment methods.
As she has a national focus on the United States but covers international topics such as EMA decisions significantly affecting global pharmaceutical markets; pitches should balance providing relevant US perspectives while also acknowledging broader international implications.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Arun Upadhyay, PhD, discusses new study findings from trials of OCU400 (Ocugen)
The annual meeting, held in Chicago, Illinois, featured new data and best practices for patient-centered care.
By: Hattie Hayes
Optical coherence tomography will be in all eye care services by October 2025
By: Hattie Hayes
A program from National Health Service (NHS) England will bring optical coherence tomography (OCT) scans “closer to home” for thousands of patients.
This year's Barcelona meeting brought together award-winning research findings and leaders in the retina field.
The annual meeting brought announcements and insights from companies in the retina care space.
Another year is coming to its end. We spent 2024 celebrating the 20th anniversary of Ophthalmology Times Europe . That milestone wouldn't be possible
Trabecular meshwork outflow is vital for IOP regulation, with segmental flow variations impacting surgical success in glaucoma management.
By: Hattie Hayes
Semaglutide's association with NAION and its role in corneal nerve regeneration were key research topics in 2024.
By: Hattie Hayes
The EMA is reviewing Danish studies linking semaglutide to increased NAION risk, following a request from the Danish Medicines Agency.
(833) 317-6278 
